BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 31607486)

  • 21. Impact of Preoperative Skeletal Muscle Mass and Nutritional Status on Short-and Long-Term Outcomes After Esophagectomy for Esophageal Cancer: A Retrospective Observational Study : Impact of Psoas Muscle Mass and Body Mass on Esophagectomy.
    Shichinohe T; Uemura S; Hirano S; Hosokawa M
    Ann Surg Oncol; 2019 May; 26(5):1301-1310. PubMed ID: 30725311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.
    Reisinger KW; Bosmans JW; Uittenbogaart M; Alsoumali A; Poeze M; Sosef MN; Derikx JP
    Ann Surg Oncol; 2015 Dec; 22(13):4445-52. PubMed ID: 25893413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection?
    Womer AL; Brady JT; Kalisz K; Patel ND; Paspulati RM; Reynolds HL; Pawlik TM; Steele SR
    Am J Surg; 2018 Mar; 215(3):503-506. PubMed ID: 29277239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis?
    Saeki H; Nakashima Y; Kudou K; Sasaki S; Jogo T; Hirose K; Edahiro K; Korehisa S; Taniguchi D; Nakanishi R; Kubo N; Ando K; Kabashima A; Oki E; Maehara Y
    World J Surg; 2018 Sep; 42(9):2894-2901. PubMed ID: 29488065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
    Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
    Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship Between Early Postoperative Change in Total Psoas Muscle Area and Long-term Prognosis in Esophagectomy for Patients with Esophageal Cancer.
    Matsui K; Kawakubo H; Hirata Y; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    Ann Surg Oncol; 2021 Oct; 28(11):6378-6387. PubMed ID: 33786679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer.
    Sheetz KH; Zhao L; Holcombe SA; Wang SC; Reddy RM; Lin J; Orringer MB; Chang AC
    Dis Esophagus; 2013; 26(7):716-22. PubMed ID: 23350746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer.
    Yip C; Goh V; Davies A; Gossage J; Mitchell-Hay R; Hynes O; Maisey N; Ross P; Gaya A; Landau DB; Cook GJ; Griffin N; Mason R
    Eur Radiol; 2014 May; 24(5):998-1005. PubMed ID: 24535076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is radiological psoas muscle area measurement a predictor of postoperative complications after rectal resection for rectal cancer? A retrospective study.
    Uehara H; Yamazaki T; Iwaya A; Kameyama H; Utsumi S; Harada R; Komatsu M; Hirai M; Kubota A; Katada T; Kobayashi K; Sato D; Yokoyama N; Kuwabara S; Otani T
    Surg Today; 2022 Feb; 52(2):306-315. PubMed ID: 34309711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Yoden M
    Gen Thorac Cardiovasc Surg; 2019 Nov; 67(11):949-954. PubMed ID: 30972530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of long-term tube feeding intervention in preventing skeletal muscle loss after minimally invasive esophagectomy.
    Kato T; Oshikiri T; Koterazawa Y; Goto H; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Surg Today; 2024 Jun; 54(6):606-616. PubMed ID: 38150018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer.
    Delitto D; Judge SM; George TJ; Sarosi GA; Thomas RM; Behrns KE; Hughes SJ; Judge AR; Trevino JG
    Surgery; 2017 Apr; 161(4):930-938. PubMed ID: 27932030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Sarcopenia and Clinical Outcomes in Patients With Esophageal Cancer Under Neoadjuvant Therapy.
    Huang CH; Lue KH; Hsieh TC; Liu SH; Wang TF; Peng TC
    Anticancer Res; 2020 Feb; 40(2):1175-1181. PubMed ID: 32014971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma.
    Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 30809629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient's Skeletal Muscle Radiation Attenuation and Sarcopenic Obesity are Associated with Postoperative Morbidity after Neoadjuvant Chemoradiation and Resection for Rectal Cancer.
    Berkel AEM; Klaase JM; de Graaff F; Brusse-Keizer MGJ; Bongers BC; van Meeteren NLU
    Dig Surg; 2019; 36(5):376-383. PubMed ID: 29898443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia.
    Reeve TE; Ur R; Craven TE; Kaan JH; Goldman MP; Edwards MS; Hurie JB; Velazquez-Ramirez G; Corriere MA
    J Vasc Surg; 2018 May; 67(5):1512-1520. PubMed ID: 29276105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?
    Mungo B; Molena D; Stem M; Yang SC; Battafarano RJ; Brock MV; Lidor AO
    Dis Esophagus; 2015 Oct; 28(7):644-51. PubMed ID: 25059343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
    Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sarcopenia as a predictor of complications and survival following radical cystectomy.
    Smith AB; Deal AM; Yu H; Boyd B; Matthews J; Wallen EM; Pruthi RS; Woods ME; Muss H; Nielsen ME
    J Urol; 2014 Jun; 191(6):1714-20. PubMed ID: 24423437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative pneumonia causes the loss of skeletal muscle volume and poor prognosis in patients undergoing esophagectomy for esophageal cancer.
    Fujishima S; Tsujimoto H; Nagata K; Sugasawa H; Nomura S; Ito N; Harada M; Sugihara T; Ishibashi Y; Kouzu K; Shinmoto H; Kishi Y; Ueno H
    Gen Thorac Cardiovasc Surg; 2021 Jan; 69(1):84-90. PubMed ID: 32914386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.